Welcome to LookChem.com Sign In|Join Free

CAS

  • or

126-18-1

Post Buying Request

126-18-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

126-18-1 Usage

Definition

ChEBI: An oxaspiro compound that is(5beta,25R)-spirostan substituted by a beta-hydroxy group at position 3.

Purification Methods

Chromatograph smilagenin on active Al2O3 and elute with *C6H6, then recrystallise it from Me2CO, aqueous EtOH (m 187-188o) or MeOH. The acetate crystallises from MeOH with m 152o and [] D 25 -59.6o, [] 546 25 –68.9o (c 0.25, CHCl3). [Askew J Chem Soc 1399 1936 and 1402 1936, Scheer et al. J Am Chem Soc 77 6411955, Beilstein 19 III/IV 826.]

Check Digit Verification of cas no

The CAS Registry Mumber 126-18-1 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 1,2 and 6 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 126-18:
(5*1)+(4*2)+(3*6)+(2*1)+(1*8)=41
41 % 10 = 1
So 126-18-1 is a valid CAS Registry Number.
InChI:InChI=1/C27H44O3/c1-16-7-12-27(29-15-16)17(2)24-23(30-27)14-22-20-6-5-18-13-19(28)8-10-25(18,3)21(20)9-11-26(22,24)4/h16-24,28H,5-15H2,1-4H3/t16?,17-,18+,19-,20?,21?,22?,23-,24-,25-,26-,27+/m0/s1

126-18-1SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name (25R)-5β-spirostan-3β-ol

1.2 Other means of identification

Product number -
Other names Spirostan-3-ol, (3β,5β,25R)-

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:126-18-1 SDS

126-18-1Synthetic route

26-O-β-D-glucopyransoyl-(25R)-5β-furostane-3β,22ξ,26-triol 3-O-[β-D-xylopyranosyl (1->6)]-β-D-glucopyranside

26-O-β-D-glucopyransoyl-(25R)-5β-furostane-3β,22ξ,26-triol 3-O-[β-D-xylopyranosyl (1->6)]-β-D-glucopyranside

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride In ethanol for 3h; Heating;82.7%
sarsasapogenin
126-19-2

sarsasapogenin

A

(2S,4aS,4bS,6aS,6bR,7R,9aS,10aS,10bR,12aR)-2-Hydroxy-4a,6a,7-trimethyl-octadecahydro-9-oxa-pentaleno[2,1-a]phenanthren-8-one

(2S,4aS,4bS,6aS,6bR,7R,9aS,10aS,10bR,12aR)-2-Hydroxy-4a,6a,7-trimethyl-octadecahydro-9-oxa-pentaleno[2,1-a]phenanthren-8-one

B

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With trimethylsilyl trifluoromethanesulfonate; 3-chloro-benzenecarboperoxoic acid at 20℃; for 96h;A 13%
B 48%
sarsasapogenin
126-19-2

sarsasapogenin

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride; ethanol
smilagenin 3-O-β-D-glucopyranosyl-(1->2)-<β-D-glucopyranosyl-(1->3)>-β-D-glucopyranoside

smilagenin 3-O-β-D-glucopyranosyl-(1->2)-<β-D-glucopyranosyl-(1->3)>-β-D-glucopyranoside

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride In methanol for 2h; Heating;
smilagenin 3-O-β-D-glucopyranosyl-(1->2)-<β-D-glucopyranosyl-(1->3)>-β-D-galactopyranoside
122620-12-6

smilagenin 3-O-β-D-glucopyranosyl-(1->2)-<β-D-glucopyranosyl-(1->3)>-β-D-galactopyranoside

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride In methanol for 2h; Heating;
(25R)-5β-spirostan-3β-ol-3-O-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside

(25R)-5β-spirostan-3β-ol-3-O-β-D-glucopyranosyl-(1->2)-β-D-glucopyranoside

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride In methanol for 2h; Heating;
(25R)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1''->2')-O-β-D-galactopyranoside

(25R)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1''->2')-O-β-D-galactopyranoside

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride In methanol for 2h; Heating;
(25R,S)-5b-spirostan-3β-ol 3-O-

(25R,S)-5b-spirostan-3β-ol 3-O-

A

smilagenin
126-18-1

smilagenin

B

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane for 2h; Heating; Title compound not separated from byproducts;
(25R)-5β-spirostan-3β-ol 3-O-

(25R)-5β-spirostan-3β-ol 3-O-

A

smilagenin
126-18-1

smilagenin

B

sarsasapogenin
126-19-2

sarsasapogenin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane for 2h; Heating; Title compound not separated from byproducts;
smilonine

smilonine

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride; ethanol
hydrogenchloride
7647-01-0

hydrogenchloride

ethanol
64-17-5

ethanol

water
7732-18-5

water

sarsasapogenin
126-19-2

sarsasapogenin

A

smilagenin
126-18-1

smilagenin

B

(25R)-5β-spirost-2(or 3)-ene

(25R)-5β-spirost-2(or 3)-ene

(25R)-3-O-(β-D-xylopyranosyl-(1->2)-β-D-galactopyranosyl)-5β-spirostan-3β-ol
1005340-18-0

(25R)-3-O-(β-D-xylopyranosyl-(1->2)-β-D-galactopyranosyl)-5β-spirostan-3β-ol

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride In 1,4-dioxane at 95℃; for 6h;
(25R)-5β-spirostan-3β-yl O-β-D-glucopyranosyl-(1->4)-β-D-galactopyranoside
1176316-07-6

(25R)-5β-spirostan-3β-yl O-β-D-glucopyranosyl-(1->4)-β-D-galactopyranoside

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride; water In 1,4-dioxane at 95℃; for 2h; Inert atmosphere;3 mg
(25R)-5β-spirostan-3β-yl O-β-D-glucopyranosyl-(1->3)-β-D-galactopyranoside
1176316-09-8

(25R)-5β-spirostan-3β-yl O-β-D-glucopyranosyl-(1->3)-β-D-galactopyranoside

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride; water In 1,4-dioxane at 95℃; for 2h; Inert atmosphere;3.5 mg
(25R)-5β-spirostan-3β-yl O-β-D-glucopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->4)-β-D-galactopyranoside
1176316-11-2

(25R)-5β-spirostan-3β-yl O-β-D-glucopyranosyl-(1->2)-O-β-D-glucopyranosyl-(1->4)-β-D-galactopyranoside

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride; water In 1,4-dioxane at 95℃; for 2h; Inert atmosphere;2.9 mg
(25R)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1''->2')-O-β-D-galactopyranoside

(25R)-5β-spirostan-3β-ol 3-O-β-D-glucopyranosyl-(1''->2')-O-β-D-galactopyranoside

A

D-glucose
50-99-7

D-glucose

B

D-Galactose
59-23-4

D-Galactose

C

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With water Acidic conditions;
(25R)-5β-spirostan-3β-yl-O-β-D-glucopyranosyl-(1→4)-O-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranoside

(25R)-5β-spirostan-3β-yl-O-β-D-glucopyranosyl-(1→4)-O-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranoside

A

D-Glucose
2280-44-6

D-Glucose

B

L-rhamnose
73-34-7

L-rhamnose

C

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With naringinase In aq. acetate buffer at 20℃; for 432h; pH=4.3; Enzymatic reaction;A n/a
B n/a
C 0.3 mg
(25R)-26-[(β-D-glucopyranosyl)oxy]-22α-hydroxy-5β-furostan-3β-yl-O-β-D-glucopyranosyl-(1→4)-O-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranoside

(25R)-26-[(β-D-glucopyranosyl)oxy]-22α-hydroxy-5β-furostan-3β-yl-O-β-D-glucopyranosyl-(1→4)-O-[α-L-rhamnopyranosyl-(1→2)]-β-D-glucopyranoside

A

D-Glucose
2280-44-6

D-Glucose

B

L-rhamnose
73-34-7

L-rhamnose

C

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride; water In 1,4-dioxane at 95℃; for 2h; Inert atmosphere;A n/a
B n/a
C 1.9 mg
smilagenin-3-O-{β-D-glucopyranosyl-(1→6)-O-β-D-galactopyranoside}

smilagenin-3-O-{β-D-glucopyranosyl-(1→6)-O-β-D-galactopyranoside}

A

D-glucose
50-99-7

D-glucose

B

D-Galactose
59-23-4

D-Galactose

C

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
With hydrogenchloride; water In 1,4-dioxane at 95℃; for 4h;
diosgenin
512-04-9

diosgenin

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: aluminum isopropoxide / toluene; cyclohexanone / 6 h / 100 °C
2: 5%-palladium/activated carbon; hydrogen / methanol / 4 h / 60 °C
3: sodium tetrahydroborate / tetrahydrofuran / 20 °C
View Scheme
(25R)-spirost-4-ene-3-one
6870-79-7

(25R)-spirost-4-ene-3-one

smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 5%-palladium/activated carbon; hydrogen / methanol / 4 h / 60 °C
2: sodium tetrahydroborate / tetrahydrofuran / 20 °C
View Scheme
smilagenin
126-18-1

smilagenin

3β-hydroxy-23,24-dinor-5β-cholano-22,16-lactone
514-33-0, 5665-64-5, 32845-62-8

3β-hydroxy-23,24-dinor-5β-cholano-22,16-lactone

Conditions
ConditionsYield
Stage #1: smilagenin With sulfuric acid; iodine; acetic acid at 20℃; for 0.166667h;
Stage #2: With peracetic acid; acetic acid for 14h;
Stage #3: With sodium hydroxide at 20℃; pH=13;
86%
smilagenin
126-18-1

smilagenin

3α-amino-5β,20α,22α,25R-spirostane
349082-95-7

3α-amino-5β,20α,22α,25R-spirostane

Conditions
ConditionsYield
Stage #1: smilagenin With methanesulfonyl chloride; triethylamine In dichloromethane
Stage #2: With sodium azide In dimethyl sulfoxide at 70℃;
Stage #3: With 10 wt% Pd(OH)2 on carbon; hydrogen
81%
Multi-step reaction with 2 steps
1.1: triphenylphosphine / tetrahydrofuran / 0.5 h / 0 °C / Inert atmosphere
1.2: 3 h / Inert atmosphere
2.1: hydrazine hydrate / methanol / 55 °C
View Scheme
smilagenin
126-18-1

smilagenin

(3β,5β,22β,25R)-furostane-3,26-diol

(3β,5β,22β,25R)-furostane-3,26-diol

Conditions
ConditionsYield
With sodium cyanoborohydride In acetic acid for 2.5h; Ring cleavage;76%
ethylmagnesium bromide
925-90-6

ethylmagnesium bromide

smilagenin
126-18-1

smilagenin

(25R)-22-ethyl-5β,22ξH-furostan-3β,26-diol
107013-19-4

(25R)-22-ethyl-5β,22ξH-furostan-3β,26-diol

Conditions
ConditionsYield
With diethyl ether anschliessend in Benzol erwaermen;
acetic anhydride
108-24-7

acetic anhydride

smilagenin
126-18-1

smilagenin

smilagenin acetate
4947-75-5

smilagenin acetate

Conditions
ConditionsYield
With pyridine
benzoyl chloride
98-88-4

benzoyl chloride

smilagenin
126-18-1

smilagenin

O-Benzoyl-smilagenin
4952-69-6

O-Benzoyl-smilagenin

Conditions
ConditionsYield
With pyridine
smilagenin
126-18-1

smilagenin

(20S)-5β-pregnan-3β,16β,20-triol
72984-71-5

(20S)-5β-pregnan-3β,16β,20-triol

Conditions
ConditionsYield
With potassium sulfate; dipotassium peroxodisulfate; acetic acid weiteres Reagens: konz. Schwefelsaeure;
smilagenin
126-18-1

smilagenin

(25R)-5β-cholestanetriol-(3β.16β.26)
26541-65-1, 53861-12-4, 105120-39-6

(25R)-5β-cholestanetriol-(3β.16β.26)

Conditions
ConditionsYield
With hydrogenchloride; amalgamated zinc; ethanol
Conditions
ConditionsYield
With acetic acid; platinum Hydrogenation;
smilagenin
126-18-1

smilagenin

(25R)-3α-chloro-5β-spirostan

(25R)-3α-chloro-5β-spirostan

Conditions
ConditionsYield
With carbon disulfide; chloroform; phosphorus pentachloride
smilagenin
126-18-1

smilagenin

(25R)-5β-furost-20(22)-ene-3β,26-diol
11005-21-3

(25R)-5β-furost-20(22)-ene-3β,26-diol

Conditions
ConditionsYield
With potassium hydroxide; acetic anhydride at 200℃;
With potassium hydroxide; Octanoic acid; acetic anhydride at 240℃;
Multi-step reaction with 2 steps
2: acetic acid anhydride; methanol. KOH-solution / 200 °C
View Scheme
smilagenin
126-18-1

smilagenin

O-(2-bromo-benzoyl)-smilagenin

O-(2-bromo-benzoyl)-smilagenin

smilagenin
126-18-1

smilagenin

A

7α-hydroxysarsasapogenin

7α-hydroxysarsasapogenin

B

smilagenin acetate
4947-75-5

smilagenin acetate

Conditions
ConditionsYield
With potassium dihydrogenphosphate; D-glucose; Fusarium lini; glycerol; sodium chloride; peptone; yeast extract In water for 288h;
smilagenin
126-18-1

smilagenin

Fusarium lini

Fusarium lini

A

7α-hydroxysarsasapogenin

7α-hydroxysarsasapogenin

B

smilagenin acetate
4947-75-5

smilagenin acetate

Conditions
ConditionsYield
With potassium dihydrogenphosphate; D-glucose; glycerol; sodium chloride; peptone; yeast extract In water for 288h;
smilagenin
126-18-1

smilagenin

(25R)-3β,26-diacetoxy-22-ethyl-5β,22ξH-furostan
107629-70-9

(25R)-3β,26-diacetoxy-22-ethyl-5β,22ξH-furostan

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: diethyl ether / anschliessend in Benzol erwaermen
View Scheme
smilagenin
126-18-1

smilagenin

Di-O-benzoyl-dihydrosmilagenin
120928-64-5, 120928-66-7

Di-O-benzoyl-dihydrosmilagenin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: platinum; acetic acid / Hydrogenation
2: pyridine
View Scheme
smilagenin
126-18-1

smilagenin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: platinum; acetic acid / Hydrogenation
2: pyridine
View Scheme
smilagenin
126-18-1

smilagenin

O26-(toluene-4-sulfonyl)-dihydrosmilagenin

O26-(toluene-4-sulfonyl)-dihydrosmilagenin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: platinum; acetic acid / Hydrogenation
2: pyridine
View Scheme
smilagenin
126-18-1

smilagenin

cyclopseudosmilagenin
428-41-1

cyclopseudosmilagenin

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: acetic acid anhydride; methanol. KOH-solution / 200 °C
2: ethanol; acetic acid
View Scheme

126-18-1Related news

Role of glial cell derived neurotrophic factor in the protective effect of SMILAGENIN (cas 126-18-1) on rat mesencephalic dopaminergic neurons damaged by MPP+09/25/2019

Tyrosine hydroxylase immunohistochemical analysis revealed that in cultured mesencephalic dopaminergic neurons smilagenin (SMI), added prior to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPP+), protected against the drop of neuron number and neurite outgrowth length caused by MPP+. Addition o...detailed

Regulation of M1-receptor mRNA stability by SMILAGENIN (cas 126-18-1) and its significance in improving memory of aged rats09/24/2019

The purpose of this work is to study the effect of smilagenin on the mRNA stability of muscarinic receptor subtype 1 (M1; m1 mRNA) in aged rat brains and its significance in improving memory. The Y-maze avoidance task showed that oral administration of smilagenin significantly improved spatial m...detailed

Synthesis and biological evaluation of 3-carbamate SMILAGENIN (cas 126-18-1) derivatives as potential neuroprotective agents09/09/2019

Studies indicated that smilagenin, isolated from Anemarrhena asphodeloides Bunge, could improve cognitive impairment and exhibit neuroprotective activity. On the basis of the structure of smilagenin, a series of derivatives were synthesized and evaluated for their neuroprotective effects of H2O2...detailed

126-18-1Relevant articles and documents

-

Wall et al.

, p. 3086,3088 (1955)

-

Steroid compounds from stems of yucca gloriosa

Benidze,Skhirtladze,Kemertelidze

, p. 518 - 519 (2012)

-

THE STEROIDAL GLYCOSIDES FROM THE CAUDEX OF YUCCA GLORIOSA

Nakano, Kimiko,Yamasaki, Tokushi,Imamura, Yukiko,Murakami, Kotaro,Takaishi, Yoshihisa,Tomimatsu, Toshiaki

, p. 1215 - 1218 (1989)

Five steroidal glycosides were isolated from the fresh caudex of Yucca gloriosa together with YG-1 and Ps-1 previously obtained from flowers and the structures of these glycosides were established to be smilagenin 3-O-β-D-glycopyranosyl-(1->2)-β-D-glucopyranoside (Ys-I), 3-O-β-D-glucopyranosyl-(1->2)-β-D-galactopyranoside (YS-II), 3-O-β-D-glucopyranosyl-(1->2)-3)>-β-D-glucopyranoside (YS-III), 3-O-β-D-glucopyranosyl-(1->2)-3)>-β-D-galactopyranoside (YS-IV) and samogenin 3-O-β-D-glucopyranosyl-(1->2)-β-D-galactopyranoside (YS-V), respectively.Key Word Index - Yucca gloriosa; Agavaceae; steroidal saponins; smilagenin glycosides; samogenin glycoside.

Concise large-scale synthesis of tomatidine, a potent antibiotic natural product

Boudreault, Pierre-Luc,Normandin, Chad

, (2021/10/12)

Tomatidine has recently generated a lot of interest amongst the pharmacology, medicine, and biology fields of study, especially for its newfound activity as an antibiotic agent capable of targeting multiple strains of bacteria. In the light of its low natural abundance and high cost, an efficient and scalable multi-gram synthesis of tomatidine has been developed. This synthesis uses a Suzuki–Miyaura-type coupling reaction as a key step to graft an enantiopure F-ring side chain to the steroidal scaffold of the natural product, which was accessible from low-cost and commercially available diosgenin. A Lewis acid-mediated spiroketal opening followed by an azide substitution and reduction sequence is employed to generate the spiroaminoketal motif of the natural product. Overall, this synthesis produced 5.2 g in a single pass in 15 total steps and 15.2% yield using a methodology that is atom economical, scalable, and requires no flash chromatography purifications.

Gram-Scale Synthesis of Tomatidine, a Steroid Alkaloid with Antibiotic Properties Against Persistent Forms of Staphylococcus aureus

Normandin, Chad,Malouin, Fran?ois,Marsault, Eric

, p. 2693 - 2698 (2020/05/04)

We herein describe the first diastereoselective synthesis of the Solanum alkaloid tomatidine 1. The synthesis has been accomplished in 11 steps and 24.9 % overall yield (longest linear sequence). This methodology, which involves a convergent synthon insertion followed by a sequence of ring opening/nitrogen substitution/ring closing, allowed the generation of 1 on > 2 g scale. The synthetic challenge with the diastereoselective generation of the unusual spiroaminoketal moiety was solved through a combined azide reduction/addition sequence. The first diastereoselective synthesis of the phytosteroid yamogenin is also reported. Tomatidine has shown promising antibiotic properties against persistent forms of Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA). In particular, it possesses the unique ability to kill persistent forms of S. aureus and MRSA while simultaneously potentiating the antibiotic efficacy of aminoglycoside antibiotics against wild type strains of the bacteria.

Steroidal Saponins from Furcraea hexapetala Leaves and Their Phytotoxic Activity

Calle, Juan M.,Pérez, Andy J.,Simonet, Ana M.,Guerra, José O.,Macías, Francisco A.

, p. 2903 - 2911 (2016/12/07)

Four new steroidal saponins (1-4) along with 13 known saponins were isolated from the leaves of Furcraea hexapetala. The new compounds were identified as (20R,22R,25R)-3β-hydroxy-5α-spirostan-12-one 3-O-{α-l-rhamnopyranosyl-(1→4)-O-β-d-glucopyranosyl-(1→3)-O-[β-d-glucopyranosyl-(1→3)-O-β-d-glucopyranosyl-(1→2)]-O-β-d-glucopyranosyl-(1→4)-O-β-d-galactopyranoside} (1), (25R)-3β-hydroxy-5α-spirost-20(21)-en-12-one 3-O-{α-l-rhamnopyranosyl-(1→4)-O-β-d-glucopyranosyl-(1→3)-O-[β-d-glucopyranosyl-(1→3)-O-β-d-glucopyranosyl-(1→2)]-O-β-d-glucopyranosyl-(1→4)-O-β-d-galactopyranoside} (2), (25R)-5α-spirostan-3β-ol 3-O-{β-d-glucopyranosyl-(1→2)-O-β-d-glucopyranosyl-(1→2)-O-β-d-glucopyranosyl-(1→4)-O-β-d-galactopyranoside} (3), and (25R)-5β-spirostan-3β-ol 3-O-{β-d-glucopyranosyl-(1→6)-O-β-d-galactopyranoside} (4) by spectroscopic analysis, including one- and two-dimensional NMR techniques, mass spectrometry, and chemical methods. The phytotoxicity of the isolated compounds against the standard target species Lactuca sativa was evaluated. Structure-activity relationships for these compounds with respect to phytotoxic effects are discussed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 126-18-1